CD4+ T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa
Author(s) -
Elvin Geng,
Torsten B. Neilands,
Rodolphe Thiébaut,
Mwebesa Bwana,
Denis Nash,
Richard D. Moore,
Robin Wood,
Djimon Marcel Zannou,
Keri N. Althoff,
Poh Lian Lim,
Jean B. Nachega,
Philippa Easterbrook,
Andrew Kambugu,
Francesca Little,
Gertrude Nakigozi,
Damalie Nakanjako,
Valerian Kiggundu,
Patrick Chung Ki Li,
David R. Bangsberg,
Matthew P. Fox,
Hans Prozesky,
Peter W. Hunt,
MaryAnn Davies,
Steven J. Reynolds,
Matthias Egger,
Constantin T. Yiannoutsos,
Eric Vittinghoff,
Steven G. Deeks,
Jeffrey N. Martin
Publication year - 2015
Publication title -
international journal of epidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.406
H-Index - 208
eISSN - 1464-3685
pISSN - 0300-5771
DOI - 10.1093/ije/dyu271
Subject(s) - efavirenz , nevirapine , medicine , confidence interval , antiretroviral therapy , immunology , viral load , demography , virology , human immunodeficiency virus (hiv) , sociology
Even among HIV-infected patients who fully suppress plasma HIV RNA replication on antiretroviral therapy, genetic (e.g. CCL3L1 copy number), viral (e.g. tropism) and environmental (e.g. chronic exposure to microbial antigens) factors influence CD4 recovery. These factors differ markedly around the world and therefore the expected CD4 recovery during HIV RNA suppression may differ globally.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom